Fathers face a higher risk of postpartum depression if testosterone levels drop 9 months after the baby is born.
The rapidity of symptom remission (within 24 hours) and its efficacy are exciting developments in finding a novel treatment for PPD.
Physical activity is a safe and effective strategy for preventing depressive symptoms in pregnant and postpartum women.
Both postpartum and prenatal depression are among the most significant contributors to maternal morbidity and mortality.
Despite being one of the most commonly used drugs little research has been conducted on oxytocin's affects.
Sleep duration was significantly longer and there was less sleep disruption for pregnant women in the sleep enhancement training group compared with that of women in control groups.
The First Baby Study at Penn State College of Medicine includes more than 3 000 women in Pennsylvania having their first baby.
Oxytocin levels predicted the severity of postpartum depression symptoms among women with a history of depression.
Psychiatry Advisor Articles
- The Current State of Autism: From Etiology to Treatment
- Adjunctive Telmisartan's Effects on Symptoms of Schizophrenia
- Is Aspirin Use Associated With a Decreased Incidence of Depressive Symptoms?
- Long-Term Cariprazine Safe, Tolerable for Schizophrenia
- Augmentation Therapy for Treatment-Resistant Major Depressive Disorder
- emPATH Units as a Solution for ED Psychiatric Patient Boarding
- Antidepressants for Poststroke Depression: Comparative Efficacy and Acceptability
- New Model Shows High Accuracy in Predicting Response to Lithium
- Frequent Cannabis Use Associated With Increased Likelihood of MDD
- Protecting the Brain: The Damaging Impact of Traumatic Brain Injury
- Undertreatment of ADHD in US Adults: An Unmet Need
- Sexual Dysfunction in Patients With Major Depressive Disorder in Remission
- Predictors of Optimal Schizophrenia Outcomes Using PP1M, PP3M Treatment
- Cariprazine Effective for Long-Term Sustained Remission in Patients with Schizophrenia
- High Serum Concentrations of Second-Generation Antipsychotics in Elderly